Epic™
Vascular Self-Expanding Stent System
Ideal for the Iliac: The Epic Stent is a self-expanding Nitinol stent designed to sustain vessel patency, while providing enhanced visibility and accuracy during placement.
Explore
Product Details
Epic Stent System provides exactly the right balance
Exceptional Flexibility
|
![]() |
Balanced Radial Force
|
![]() |
Excellent Deployment Accuracy
|
![]() |
Fracture Resistance
|
![]() |
![Epic Vascular Self-Expanding Stent System Schematic](https://www.bostonscientific.com/en-EU/products/stents-vascular/Epic-Vascular-Self-Expanding-Stent-System/_jcr_content/maincontent-par/image.img.Epic_schematic.png)
Product Specifications
Stent Diameters | 6 to 12 mm |
Stent Lengths | 20, 30, 40, 60, 80, 100, 120 mm |
Catheter Lengths | 75, 120 cm |
Guide Wire System | 0.035" OTW |
Introducer Sheath Compatibility | 6 F across all sizes |
Catheter Nominal O.D. | 0.079" to 0.077" (distal to proximal) |
Epic Stent Size Matrix
6 F Compatibility Across All Sizes | ||||||||
Length (mm) | ||||||||
Diameter (mm) | ||||||||
20 | 30 | 40 | 60 | 80 | 100 | 120 | ||
6 | ||||||||
7 | ||||||||
8 | ||||||||
9 | ||||||||
10 | ||||||||
12 | ||||||||
Catheter lengths: 75 cm, 120 cm Guidewire system: 0.035" OTW |
ORION Clinical Information
![]() |
• 0 amputations at 3 years (106 subjects) • 89.9% Freedom from TLR at 3 years (143 lesions) |
US IDE Clinical Trial to demonstrate similar patency across all TASC classifications |
12-month Primary Patency by TASC Classification
![chart:12-month primary patency at TASC classification](https://www.bostonscientific.com/en-EU/products/stents-vascular/Epic-Vascular-Self-Expanding-Stent-System/_jcr_content/maincontent-par/image_2.img.Epic_chart_patency_475x.png)
12-month data
- 0% MI at 30 days (0/111)
- 3.4% MAE at 9-months (4/117)
- 0% MI in-hospital (0/111)
- 5.4% TVR at 12-months (6/111)
- 0% Amputation of index limb at 12-months (0/111)
![12-month Primary data image 12-month Primary data image](/content/dam/bostonscientific/pi/portfolio-group/Stents/Epic/Epic_chart_circle_2.png)
Composite Success Rates
![Composite Success Rates image Composite Success Rates image](/content/dam/bostonscientific/pi/portfolio-group/Stents/Epic/Epic_charts_composite_380x.png)
- 100% Technical Success
(Per lesion) (166/166)
- 99.2% Procedural Success
(Per subject) (124/125)
- 95.3% Late Clinical Success at 12 months
- (Per subject) (101/106)
Tools and Resources
-
Aug 24, 2017
MRI Compatibility for PI Products
Magnetic Resonance Imaging (MRI) Safety for Boston Scientific Peripheral Products PDF, 272.0 KB